Dechert Advises ARCHIMED on investment in Laboratoires Rivadis group

Dechert advised ARCHIMED, one of the leading international private equity firms specializing in the healthcare sector, in connection with its investment in Laboratoires Rivadis, a family-owned company specializing in hygiene, personal care, and cosmetic products for families and seniors.

ARCHIMED was advised by Vianney Toulouse and Yona Elfassi, members of Dechert's Corporate and M&A/Life Sciences team led by Alain Decombe. Labor national partner Thibault Meiers, also participated in this transaction.

About Dechert

Dechert is the law firm that helps business leaders lead.

For more than 150 years, we have advised clients on critical issues - from high-stakes litigation to first-in-market transaction structures and complex regulatory matters. Our nearly 1,000 lawyers in commercial centers worldwide are immersed in the key sectors we serve - financial services, private capital, real estate, life sciences and technology.

Dechert delivers unwavering partnership so our clients can achieve unprecedented results.

Dechert's Paris office is a key component of the firm's strategy in Europe and is active in antitrust/competition and European law, corporate/M&A, financial services & asset management, financing, intellectual property, labor and employment, litigation and compliance, regulatory and tax.

Dechert's life sciences team in France represents companies ranging from multinational giants to emerging companies involving all aspects of the life sciences industry, including pharmaceuticals, biotechnology, drug discovery, genomics, biopharmaceuticals, diagnostics, medical devices and health care. We also assist investment funds with life sciences investments. Read more »